HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nik Sol Selected Research

Nik Sol Research Topics

Disease

13Neoplasms (Cancer)
05/2023 - 01/2014
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2023 - 01/2017
2Neoplasm Metastasis (Metastasis)
05/2023 - 10/2020
2Glioma (Gliomas)
11/2022 - 06/2015
2Multiple Sclerosis
10/2020 - 07/2020
2Glioblastoma (Glioblastoma Multiforme)
10/2020 - 09/2013
1Ovarian Neoplasms (Ovarian Cancer)
01/2023
1Lung Neoplasms (Lung Cancer)
01/2023
1Pulmonary Hypertension
10/2022
1Sarcoma (Soft Tissue Sarcoma)
05/2020
1Aneuploidy (Aneuploid)
09/2013

Drug/Important Bio-Agent (IBA)

13RNA (Ribonucleic Acid)IBA
05/2023 - 11/2015
12Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2014
6tetraethylpyrazine (TEP)IBA
01/2023 - 11/2015
3Proteins (Proteins, Gene)FDA Link
11/2022 - 01/2014
2Messenger RNA (mRNA)IBA
05/2023 - 11/2015
1NivolumabIBA
05/2023
1Complement System Proteins (Complement)IBA
01/2023
1Cell-Free Nucleic AcidsIBA
11/2022
1AS 195IBA
10/2022
1AnticoagulantsIBA
10/2022
1Circular RNAIBA
09/2021
1Nucleic AcidsIBA
06/2015
1Protein Kinases (Protein Kinase)IBA
01/2014
1Phosphotransferases (Kinase)IBA
01/2014
11- (4- (6- (2- (isopropylsulfonyl)phenylamino)- 9H- purin- 2- ylamino)- 3- ethoxyphenyl)piperidin- 4- olIBA
09/2013
1Vincristine (Oncovin)FDA LinkGeneric
09/2013
1Paclitaxel (Taxol)FDA LinkGeneric
09/2013
1Antimitotic AgentsIBA
09/2013

Therapy/Procedure

1Immunotherapy
05/2023
1Therapeutics
11/2022